5 Reasons why this will fall post R/S
1) The company has not yet announced any timelines. Nor do we know any details about the company. They do not have a website currently which is the new company. Eparent is no longer part of EPGL. They will have to announce specific company details including website, the new CEO, directors and other staff. A physical location is always nice if you're planning to invest money in something too.
2) The company has NO/0 reported income. Marketing and selling a product takes capital which this company has yet to show any. They will need to announce where their financing to produce and market a medical device will come from.
3) The MPDD device may or may not be ready for production. It takes time to develop and source manufacturers and set up machinery for the manufacturing process. In addition there will be packaging, possible training and other education that will have to accompany the device.
4) We know absolutely nothing that has been more than "I called PWC and they said" as to the details of the equity holders restriction and whether they can sell into each PR that the new company releases. The full disclosure of whether the shares are restricted or not, will need to become transparent.
5) For the company to succeed and "build shareholder value" they will need to answer all of these questions as well as release PR's regarding MPDD sales contracts, release timely filings and financial statements.
If at least half of these questions are not answered pre-R/S there's no doubt that this stock won't sustain 00's for very long. They have 4 trading days to do so...
Disagree if you like, but nothing above is not factual here. They have given shareholders nothing concrete to this point...just dreams until it becomes real with the above info.
AI
News 
Market Data 
Discover 
